Pay in 4 interest-free payments of $5.16 Learn more
Ships within 48 hours · Estimated delivery Nov 6 - Nov 11
However, larger and longer-term studies are still needed to comprehensively evaluate its impact on key liver issues and fully assess its safety profile
WADA Prohibition While GLP1 and cagrilintide individually have not been explicitly listed by WADA, several considerations apply: GLP-1 agonist precedent Other GLP-1 agonists are monitored for potential misuse in athletics Weight-class sports concern Rapid weight reduction capabilities raise concerns for sports with weight classifications Performance-enhancing potential Metabolic effects could theoretically affect athletic performance Monitoring program possible May be added to WADA monitoring program as use increases Athletes should consult with their sports governing bodies and anti-doping authorities before considering any GLP-1 or amylin analogue use
Men who cannot tolerate the gastrointestinal effects of semaglutide or tirzepatide may find cagrilintide more manageable as a standalone option
Even nutritious foods can cause discomfort when consumed in quantities that exceed the stomach's capacity
Security Check
US$ 21.13
US$ 20.16
US$ 26.96
